Condition
Spinal Cord Neoplasms
Total Trials
7
Recruiting
1
Active
2
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
28.6%
2 terminated out of 7 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Terminated2
Completed2
Active Not Recruiting1
Recruiting1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07488702Active Not RecruitingPrimary
Intradurale Spinal Tumors: Management and Treatment
NCT03593330Not ApplicableTerminated
Neurosurgical Transitional Care Programme
NCT06042946Recruiting
Microsurgical Resection of Intramedullary Spinal Cord Metastases
NCT05096468Phase 2Completed
Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms.
NCT00974623Terminated
Bone Graft Materials Observational Registry
NCT02603874Not ApplicableUnknownPrimary
The Development of a Vertebra Localizing Aid Medical Device
NCT02494622CompletedPrimary
Alternative Treatment of Giant Spinal Schwannomas
Showing all 7 trials